Brief: Denali Therapeutics Q1 Operating Expenses USD 137.357 Million
07/05/2026 21:01
May 07 (Reuters) - Denali Therapeutics Q1 operating income USD -137.357 million. Q1 basic EPS USD -0.69 Q1 net income USD -128.447 million
Recent news on Denali Therapeutics
See all newsDenali Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Denali Therapeutics Q2 net loss widens as AVLAYAH launch costs rise
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed
U.S. STOCKS ON THE MOVE-Sweetgreen, Dell Technologies, Peloton Interactive
U.S. STOCKS ON THE MOVE-IMAX, Novo Nordisk, PC makers